 |
 |
Nesiritide, sebaliknya disebut rekombinan tipe-B natriuretik peptida (BNP), aplikasi nya restoratif dampak oleh fokus pada natriuretik peptida reseptor dalam the pembuluh darah dan ginjal. By actuating ini reseptor, it prompts vasodilatasi and advances sodium and water discharge, in this way lessening both preload and afterload on the heart.
One of the essential instruments by which it impacts preload is through its vasodilatory consequences for the venous framework. By enlarging veins, it diminishes venous re-visitation of the heart, subsequently decreasing preload. This decrease in preload diminishes the extending of myocardial strands during diastole, prompting a more ideal ventricular filling and worked on cardiovascular capability.
Selain itu, it's vasodilatory properties reach out to the blood vessel framework, where it diminishes foundational vascular opposition and hence brings down afterload. By diminishing afterload, it makes it simpler for the heart to launch blood into the foundational dissemination during systole, eventually working on cardiovascular result and reducing side effects of cardiovascular breakdown. Selain itu, it's dampak on preload dan afterload add to enhancements in other hemodynamic boundaries, like stroke volume and cardiovascular result. By streamlining preload and afterload, it improves myocardial oxygenation and perfusion, further supporting cardiovascular capability in patients with cardiovascular breakdown.
In rundown, it assumes a a pivotal part in tweaking preload and afterload in patients with cardiovascular breakdown through its vasodilatory impacts on both the venous and blood vessel frameworks. By diminishing preload and afterload, it works on cardiovascular capability, improves myocardial oxygenation and perfusion, and reduces side effects related with cardiovascular breakdown. Pemahaman ini sistem adalah fundamental untuk meningkatkan pemanfaatan dari itu dalam perawatan dari kardiovaskular kerusakan dan bekerja pada tenang hasil.
's Efek on Preload: Pengurangan Jantung Pengisian Tekanan
A dasar instrumen melalui yang itu dampak kardiovaskular kemampuan adalah oleh nya efek pada pramuat, the volume dari darah pengisian jantung's kamar selama diastole. Dengan salam untuk kardiovaskular kekecewaan, dinaikkan preload tambah untuk diperluas jantung pengisian tekanan, bisikan sisi efek suka dispnea dan edema.
Nesiritide GOES ABOUT AS A vasodilator, Instigating Unwinding of both venous and blood vessel vessels. By widening venous vessels, it diminishes venous re-visitation of the heart, in this way diminishing preload and cardiovascular filling pressures. This decrease in preload reduces side effects of clog and works on cardiovascular capability in patients with cardiovascular breakdown.
Selain itu, it's vasodilatory impacts stretch out to blood vessel vessels, where it declines foundational vascular opposition and accordingly brings down afterload. By diminishing both preload and afterload, it advances cardiovascular capability, upgrades heart yield, and further develops tissue perfusion.
Meskipun nya hemodinamik dampak% 2c itu juga berlaku neurohormonal keseimbangan% 2c mencekik itu renin-angiotensin-aldosteron kerangka dan menahan kedatangan dari vasopresin. Ini kegiatan lebih lanjut menambahkan ke berharga konsekuensi untuk preload, afterload, dan umumnya kardiovaskular kemampuan di kardiovaskular kerusakan pasien.
By and large, it's capacity to regulate preload through venodilation assumes a vital part in overseeing side effects of blockage and working on cardiovascular capability in patients with cardiovascular breakdown. Understanding the components fundamental it's consequences for preload is fundamental for streamlining its utilization and further developing results in cardiovascular breakdown the board.
Nesiritide
Meskipun nya konsekuensi untuk preload, it demikian juga dampak afterload, the obstruksi melawan yang hati harus menyedot darah ke dalam fundamental aliran. Dinaikkan afterload put an diperluas tanggung jawab on hati dan bisa bahan bakar samping efek in pasien dengan kardiovaskular kerusakan.
Nesiritide goes about as a vasodilator, cauusing unwinding of blood vessel vessels and diminishing fundamental vascular opposition. By diminishing afterload, it decreases the responsibility on the heart and works on cardiovascular productivity. This decrease in afterload helps upgrade cardiovascular result and myocardial oxygenation, at last further developing side effects and results in patients with cardiovascular breakdown.
Klinis Implikasi dari Nesiritide's Efek aktif Pramuat dan Afterload
Itu hemodinamik dampak dari itu on preload dan afterload memiliki besar klinis konsekuensi untuk administrasi dari kardiovaskular kerusakan. Oleh mengurangi preload% 2c it meringankan sisi efek dari menyumbat suka dyspnea dan edema% 2c bekerja on tenang solace dan pribadi kepuasan.
Pada dasarnya, by lessening afterload, it diminishes the responsibility on the heart and works on cardiovascular proficiency, prompting enhancements in heart result and tissue perfusion. These impacts add to the suggestive help and further developed results saw with it treatment in patients with cardiovascular breakdown.
Semua dalam semua, Nesiritide Berlaku menguntungkan dampak on preload dan afterload in pasien dengan kardiovaskular kerusakan melalui ITS vasodilatory aktivitas. By lessening jantung mengisi tekanan dan dasar vaskular obstruksi, IT EASES SIDE EFFECTS OF CLOAK and work on cardiovascular capability. Understanding the components fundamental it's impacts on preload and afterload is fundamental for advancing its utilization and further developing results in cardiovascular kerusakan papan .
Referensi
1. Pabrik, Robert M., et al. " Wellbeing and Viability of it in Patients with Decompensated Cardiovascular breakdown." New Britain Diary of Medication, vol. 347, no. 19, 2002, pp. 1617-1625.
2. Abraham, William T., et al. " Wellbeing and Hemodynamic Impacts of Intravenous it (Human B-Type Natriuretic Peptide) in Systolic Cardiovascular breakdown: A Portion Going Review." Course, vol. 102, no. 18, 2000, pp. 2416-2421.
3. Colucci, Wilson S., et al. " it in the Treatment of Decompensated Cardiovascular breakdown: Influence on Provincial Blood Stream and Right Ventricular Capability." Course, vol. 106, no. 22, 2002, pp. 293-296.
4. Givertz, Michael M., et al. " Transient Mixture of it for Treatment of Decompensated Cardiovascular breakdown: A Randomized Controlled Preliminary." JAMA, vol. 287, no. 12, 2002, pp. 1531-1540.
5. Stevenson, Lynne Warner, et al. " Designated Pharmacologic Treatment for Decompensated Cardiovascular breakdown: A Logical Assertion from the American Heart Affiliation." Course, vol. 112, no. 21, 2005, pp. 3958-3968.